[Relationship between protein binding and antimicrobial activities of antibiotics against Streptococcus pneumoniae

Hiroshi Sakata1

  • 1Department of Pediatrics, Asahikawa Kosei Hospital.

Insights

Tebipenem and panipenem showed high activity against Streptococcus pneumoniae, while cefditoren and meropenem were most effective against Haemophilus influenzae. Albumin-containing broth increased MIC90 values for tested antibiotics.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Pediatric bloodstream infections pose significant health risks.
  • Streptococcus pneumoniae and Haemophilus influenzae are common bacterial pathogens in children.
  • Antimicrobial resistance necessitates ongoing surveillance and evaluation of drug efficacy.

Purpose of the Study:

  • To evaluate the in vitro antimicrobial activity of various antibiotics against clinical isolates of Streptococcus pneumoniae and Haemophilus influenzae.
  • To compare antibiotic susceptibility testing using standard broth versus albumin-containing broth.
  • To identify effective oral and intravenous antibiotic options for treating pediatric infections caused by these pathogens.

Main Methods:

  • Microbroth dilution method was employed for susceptibility testing.
  • Fifty S. pneumoniae and 42 H. influenzae isolates were tested.
  • Testing was performed in both standard broth and broth supplemented with 4.5% albumin.

Main Results:

  • Tebipenem exhibited the highest oral activity against S. pneumoniae (MIC90 ≤ 0.06 µg/mL).
  • Panipenem demonstrated the highest intravenous activity against S. pneumoniae (MIC90 ≤ 0.12 µg/mL).
  • Cefditoren showed the highest oral activity against H. influenzae (MIC90 ≤ 0.06 µg/mL).
  • Meropenem displayed the highest intravenous activity against H. influenzae (MIC90 ≤ 0.06 µg/mL).
  • Albumin-containing broth resulted in higher MIC90 values compared to standard broth, particularly for highly protein-bound antibiotics.

Conclusions:

  • Tebipenem, panipenem, cefditoren, and meropenem are potent agents against the studied S. pneumoniae and H. influenzae isolates.
  • The presence of albumin in testing media significantly impacts antibiotic MIC90 values, reflecting in vivo conditions.
  • These findings aid in optimizing antibiotic selection for pediatric infections caused by these common pathogens.

Related Concept Videos

Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...